M. Flowers

Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: A prospective, randomized trial

H. Deeg, K. Sullivan, R. Storb, 1997 .

Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.

D. Parenti, A. Elmaagacli, K. van Besien, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

M. Sorror, R. Storb, B. Sandmaier, 2020, Annals of Internal Medicine.

Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin

H. Deeg, C. McFarland, M. Sorror, 2021, Bone Marrow Transplantation.

Chronic graft-versus-host-disease treatment in Brazil: analyses of failure-free survival.

L. Daudt, A. Seber, E. Miranda, 2023, Transplantation and cellular therapy.

astrointestinal Graft-versus-Host Disease in ecipients of Autologous Hematopoietic Stem Cells: ncidence, Risk Factors, and Outcome

D. Hockenbery, T. Gooley, G. McDonald, 2006 .

Early posttransplant spirometry is associated with the development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplant.

Stephanie J. Lee, G. Schoch, Qianchuan He, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.